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utophagy is generally considered to
be antipathogenic. The autophagy
gene ATG16L1 has a commonly occurring
mutation associated with Crohn disease
(CD) and intestinal cell abnormalities. Mice hypomorphic for ATG16L1
(ATG16L1HM) recreate specific features
of CD. Our recent study shows that the
same ATG16L1HM mice that are susceptible to intestinal inflammatory disease are
protected from urinary tract infections
(UTI), a common and important human
disease primarily caused by uropathogenic E. coli (UPEC). UPEC colonize
the bladder and exhibit both luminal and
intra-epithelial stages. The host responds
by recruiting innate immune cells and
shedding infected epithelial cells to clear
infection. Despite these countermeasures, UPEC can persist within the bladder epithelium as membrane-enclosed
quiescent intracellular reservoirs (QIRs)
that can seed recurrent UTI. The mechanisms of persistence remain unknown.
In this study, we show that ATG16L1
deficiency protects the host against acute
UTI and UPEC latency. ATG16L1HM
mice clear urinary bacterial loads more
rapidly and thoroughly due to ATG16L1deficient innate immune components.
Furthermore, ATG16L1HM mice exhibit
superficial urothelial cell-autonomous
architectural aberrations that also result
in significantly reduced QIR numbers.
Our findings reveal a host-protective
effect of ATG16L1 deficiency in vivo
against a common pathogen.
Recent reviews highlight the complex
interplay between autophagy and microbial adaptations governing host-pathogen interaction outcomes. Autophagic
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degradation of intracellular pathogens is a
significant host defense. However, pathogens employ many strategies to evade or
subvert the autophagy machinery for
survival including retarding the maturation of autophagosomes, impairing fusion
with lysosomes, escaping to the cytosol,
and adapting to survive and replicate
within the autophagosomal or lysosomal
compartment. Recently, for example,
Kim and coworkers demonstrated the
importance of host autophagy in modulating effective antimicrobial responses
to Mycobacterium tuberculosis, and the
Celli group showed that Brucella subverts
autophagy complexes to facilitate its intracellular cycle. However, little is known
about how UPEC interact with autophagy. We previously showed that UPEC
are enclosed in LAMP1-positive vesicles
(QIRs) that resemble LAMP1-positive
spacious Listeria-containing phagosomes
(SLAPs) described by Brumell’s group.
In this study, we show that UPEC are
also targeted by the ATG16L1, LC3, and
SQSTM1/p62 proteins. Our findings for
UPEC, thus, resemble other studies on
intracellular recognition of Salmonella
enterica serovar Typhimurium, Shigella
flexneri, and Listeria monocytogenes. We
also find UPEC in double-membranous
structures in transmission electron micrographs of infected bladders (Fig. 1).
The Virgin group had previously demonstrated that ATG16L1HM mice develop
intestinal abnormalities in Paneth cells.
Our work shows that ATG16L1 deficiency
induces multiple, baseline abnormalities in cellular components that UPEC
encounter during infection. ATG16L1deficient cells dramatically accumulate
multivesicular bodies, lysosomes and the
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UPEC receptor (UPK1A/UP1a). The
aberrations are intrinsic to ATG16L1deficient epithelial cells, because transferring ATG16L1-deficient hematopoietic
cells does not induce them in wild-type
epithelium, and even newly regenerating
ATG16L1-deficient superficial cells show
the same accumulations. Our study shows
that UPEC are less able to occupy their
intracellular niches to persist as QIRs in
the ATG16L1HM epithelium. We propose,
thus, that UPEC may normally utilize
ATG16L1 and possibly other autophagy proteins to establish latency, thus
ATG16L1 deficiency can be protective in
this regard. In other words, UPEC may
need the normal autophagic machinery
to persist. The mechanisms underlying
how UPEC avoid degradation or survive
in the autophagosomal niches remain to
be elucidated.
Autophagy plays multiple roles in both
innate and adaptive immunity. Recent
studies have suggested that autophagy
governs the balance between defending against pathogens and modulating
innate immunity to prevent excessive
inflammatory responses and inflammasome signaling. Lee et al., demonstrated
that ATG16L1 deficiency leads to a
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hyperinflammatory response by removing
the restriction on IL1B/IL-1β signaling
cascades and IL-6 production. Similarly,
Saitoh et al., showed that ATG16L1deficient macrophages produce high
amounts of the inflammatory cytokines
IL1B and IL18. In our study, we observed
significantly increased levels of IL-6 and
IL1A/IL-1α in infected ATG16L1HM mice
relative to controls. Furthermore, our
findings demonstrated that ATG16L1deficient hematopoietic cells, especially
neutrophils and macrophages, contribute critically to mounting a hypervigilant innate immune response, which
likely promotes the rapid clearance of
extracellular UPEC. Cadwell and Virgin
previously demonstrated enhanced transcription of pro-inflammatory cytokines
in aberrant Paneth cells of ATG16L1HM
mice. In the setting of CD and the presence of commensal bacteria, elevated proinflammatory cytokine levels induced by
ATG16L1 deficiency lead to intestinal
pathology, which is detrimental to the
host. However, in the ATG16L1-deficient
urinary tract, the elevated proinflammatory cytokine levels may have a beneficial effect, as UPEC has been shown
previously to inhibit proinflammatory
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Figure 1. UPEC enclosed within a double-membraned autophagosomal structure. TEM of bladder tissue from ATG16L1HM mice 14 d post-infection, depicting UPEC (arrowheads) enclosed in a
double-membraned autophagosomal structure (arrow). Bar: 1 μm.

cytokine production. Thus, an ATG16L1
deficiency-induced hyperinflammatory
response may help clear the infection by
countering UPEC’s ability to dampen
innate immune responses.
It is important to determine if the protection we observed is ATG16L1-specific
or represents a general effect of the autophagy pathway on UTI pathogenesis. The
autophagy machinery comprises many
essential proteins including ATG5, ATG7
and ATG12. We demonstrated that innate
immune cell-specific knockdown of Atg5
induces a similar protective phenotype as
that induced by ATG16L1 deficiency, suggesting that UPEC may hijack multiple
autophagy components to colonize and
persist in the urinary tract.
A polymorphism in ATG16L1 associated with CD can be found in up to 50%
of individuals in certain populations. It
is unclear why a seemingly unfavorable
allelic variant of ATG16L1 would occur
at such high frequency. One explanation
is that the alleles were originally selected
for a beneficial property such as protection against chronic or recurrent infectious diseases. Our results demonstrating
that ATG16L1 mutation can confer protection against UTIs could explain why
mutant alleles are unexpectedly frequent:
protection against UTIs could be a mechanism to counter the negative selection
imposed by the inflammation-promoting
effects of the ATG16L1 mutation. A better understanding of the link between
autophagy, latency, and inflammation
could lead to therapeutic approaches, for
example by targeting ATG16L1 or autophagy in general to treat recurrent UTI.
Thus, the use of inhibitors of autophagy
or ATG16L1 to eliminate latent bacterial
reservoirs may have substantial clinical
benefits to combat refractory and recurrent UTIs, because conventional antibiotics are unable to penetrate urothelial
barriers to clear bacteria sequestered as
QIRs.

